Speciality Medicines Financials

BSE: 544738

₹140.00

₹-2.00 (-1.41%)

As on 30-Oct-2026IST

Market cap

₹123 Cr

Revenue (TTM)

₹75 Cr

P/E Ratio

9.4

P/B Ratio

1.7

Div. Yield

0 %

Income Statement (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	75.29	58.27	27.52	23.24	40.44	--
Total Income	76.11	58.54	27.66	23.26	40.45	--
Total Expenditure	61.60	49.14	22.25	19.66	38.16	--
EBITDA	13.68	9.13	5.27	3.58	2.28	--
Depreciation	0.17	0.20	0.23	0.30	0.11	--
EBIT	13.51	8.93	5.04	3.28	2.17	--
Interest	1.32	0.51	0.62	0.35	0.03	--
Other Income	0.83	0.27	0.13	0.02	0.00	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	13.02	8.69	4.56	2.95	2.14	--
Provision for Tax	-0.01	1.49	1.62	1.26	0.66	--
Profit after Tax	13.03	7.20	2.93	1.69	1.48	--

Liabilities (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	71.19	30.62	15.06	5.87	1.93	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	5.15	2.78	0.86	1.16	0.01	--
Current Liabilities	18.88	6.62	6.71	6.21	3.83	--
Total Liabilities	95.22	40.01	22.68	13.26	5.78	--

Assets (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	6.26	3.59	1.69	1.90	2.23	--
Current Assets	88.97	36.42	20.94	11.34	3.55	--
Total Assets	95.22	40.01	22.68	13.26	5.78	--
Total Debt*	6.64	5.05	2.86	3.64	1.18	--
Net Current Assets	70.09	29.80	14.23	5.13	-0.28	--
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	-1.28	-6.43	-4.80	-4.21	0.81	--
Cash Flow from Investing Activities	-2.83	-1.43	-0.03	0.03	-2.33	--
Cash from Financing Activities	27.82	8.46	4.81	4.37	1.60	--
Net Cash Inflow / Outflow	23.70	0.60	-0.01	0.18	0.08	--

Financials Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	14.83	11.18	5.73	4.42	4.70	--
Cash EPS (₹)	15.03	11.49	6.19	5.19	5.05	--
Adjusted Book Value (₹)	81.03	47.58	29.44	15.36	6.13	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	-1.46	-9.99	-9.38	-11.03	38.39	--
Free Cash Flow per Share (₹)	-2.93	-11.77	-11.35	-13.89	-94.51	--

Profitability Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	25.26	34.34	37.72	52.41	69.75	--
ROE (%)	25.60	31.50	28.03	43.30	76.56	--
ROA (%)	19.27	22.97	16.36	17.77	25.61	--
EBIT Margin (%)	17.94	15.33	18.31	14.12	5.36	--
Net Margin (%)	17.12	12.29	10.61	7.26	3.66	--
Cash Profit Margin (%)	17.54	12.69	11.50	8.54	3.93	--

Growth Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	29.20	111.71	18.43	-42.54	--	--
EBIT Growth (%)	51.24	77.20	53.55	51.42	--	--
Net Profit Growth (%)	81.11	145.30	73.70	14.16	--	--
EPS Growth (%)	32.67	95.03	29.68	-5.86	--	--
Book Value Growth (%)	132.49	103.28	156.66	203.73	--	--

Valuation Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	8.49	--	--	--	--	--
Price / Book Value	1.55	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	6.39	1.13	1.43	2.00	0.57	--
Close Price (₹)	125.90	--	--	--	--	--
High Price (₹)	129.50	--	--	--	--	--
Low Price (₹)	124.00	--	--	--	--	--
Market Cap (₹ Cr)	110.62	--	--	--	--	--

Solvency Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	0.09	0.16	0.19	0.62	0.61	--
Short term debt to equity ratio	0.01	0.04	0.11	0.29	0.61	--
Current Ratio	4.71	5.50	3.12	1.83	0.93	--
Quick Ratio	3.21	2.88	1.92	1.09	0.80	--
Interest Coverage	10.87	18.03	8.39	9.33	70.21	--

Operating Efficiency Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	35.20	16.48	38.92	23.69	6.41	--
Asset Turnover	1.11	1.86	1.53	2.44	7.00	--
Receivable days	87.52	63.63	107.54	63.58	23.38	--
Inventory Days	110.76	79.57	83.72	39.87	4.35	--
Payable days	43.45	14.65	42.28	33.46	12.32	--
Cash Conversion Cycle	154.84	128.55	148.98	70.00	15.42	--